Washington, D.C. – U.S. Senator Pat Toomey (R-Pa.), the chairman of the Senate Finance Committee Subcommittee on Health Care, will convene a hearing examining the testing and treatment for Alzheimer’s disease and the fiscal implications of the disease on our federal healthcare programs on Wednesday, December 16th at 2:30 PM
 
The hearing will be streamed on the Senate Finance Committee’s website.
 
Last year, the Senate Finance Committee Subcommittee on Health Care held a hearing on the barriers to treatment and care for Alzheimer’s patients. Chairman Toomey and Ranking Member Debbie Stabenow (D-Mich.) also sought input from stakeholders  providers, researchers, patients, patient advocacy groups, states, and others  to inform the development of regulatory recommendations and potential future legislation. The senators sent a letter to the Administration in October, requesting certain regulatory actions to improve care for Alzheimer’s patients.
 
What: Hearing: “The Alzheimer’s Crisis: Examining Testing and Treatment Pipelines and Fiscal Implications.”
 
When: Wednesday, December 16th at 2:30 PM.
 
Witnesses:
 
Nikolay Dokholyan, Ph.D., M.S.
G. Thomas Passananti, Professor and Vice Chair for Research
Pennsylvania State College of Medicine, Hershey, Pa.
 
Randall J. Bateman, M.D.
Charles F. and Joanne Knight Distinguished Professor of Neurology, Director, Dominantly Inherited Alzheimer's Network (DIAN), DIAN Trials Unit
Washington University School of Medicine, St. Louis, Mo.
 
Richard Mohs, Ph.D.
Chief Scientific Officer
Global Alzheimer’s Platform Foundation, Chicago, Ill.
  
Maria Carrillo, Ph.D.
Chief Science Officer

Alzheimer’s Association, Chicago, Ill.